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Abstract. Human bystin was identified as a cytoplas-
mic protein directly binding to trophinin, a cell
adhesion molecule potentially involved in human
embryo implantation. Although the trophinin gene is
unique to mammals, the bystin gene (BYSL) is
conserved across eukaryotes. Recent studies show
that bystin plays a key role during the transition from
silent trophectoderm to an active trophoblast upon
trophinin-mediated cell adhesion. Bystin gene knock-
out and knockdown experiments demonstrate that
bystin is essential for embryonic stem cell survival and
trophectoderm development in the mouse. Further-
more, biochemical analysis of bystin in human cancer
cells and mouse embryos indicates a function in
ribosomal biogenesis, specifically in processing of
18S RNA in the 40S subunit. Strong evidence that
BYSL is a target of c-MYC is consistent with a role for
bystin in rapid protein synthesis, which is required for
actively growing cells.
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Introduction
Bystin was originally identified as a cytoplasmic
protein that forms a complex with trophinin and tastin
in human trophoblastic embryonal carcinoma HT-H
cells [1–3]. Trophinin is an intrinsic membrane
protein that mediates cell adhesion by homophilic
trophinin-trophinin binding. Tastin and bystin are
cytoplasmic proteins required for trophinin to func-
tion efficiently as a cell adhesionmolecule. In humans,
trophinin, tastin and bystin are expressed at the utero-
placental interface or at implantation sites [4, 5].
These proteins are expressed in human placenta at
early stages of pregnancy but disappear from the
placenta after 10 weeks of pregnancy [4].
Genes encoding trophinin and tastin are only found in
mammals. Knockout of trophinin in mice revealed
that trophinin does not play an essential role in
embryo implantation in that species [6]. Nevertheless,
analysis of the function of human trophinin, partic-
ularly in cases of ectopic pregnancy, supports the
hypothesis that trophinin is uniquely involved in
human embryo implantation [5].
By contrast, the bystin gene, Bysl, is conserved across
a wide range of eukaryotes, including yeast, nemat-
odes, insects, snakes, and mammals [7–11]. The yeast
Bysl homolog, ENP1 or essential nuclear protein 1, is* Corresponding author.
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required for vegetative growth in budding yeast [7]
and functions in pre-ribosomal RNA processing [8].
Biochemical and cell biological analysis of bystin in
human cancer cells and mouse embryos indicates that
bystin functions in the biogenesis of the 40S ribosome
and in cell growth [12, 13].
Involvement of bystin in human embryo implantation
A fertilized mammalian egg autonomously develops
into a blastocyst, which must be successfully implant-
ed in the uterus to develop into a fetus. In higher
primates including humans, initial adhesion of the
blastocyst to the uterus occurs via the trophectoderm
and endometrial luminal epithelial cells. Thus the
blastocyst, which is composed of a trophectoderm
monolayer surrounding embryonic stem cells or the
inner cell mass, adheres to the apical surface of the
endometrial luminal epithelia at its embryonic pole
[14–16]. This morphology of the human embryo
implantation site differs significantly from that seen in
the mouse. In mouse, an implanting blastocyst is
surrounded by endometrium, and the initial adhesion
takes place at the abembryonic pole of the mouse
blastocyst, which orients the embryo within the
implantation chamber [17, 18]. Nonetheless, in all
mammals, the initial adhesion of the blastocyst to the
uterus occurs at apical membranes of two polarized
epithelial cells, whereas, apical cell surfaces of epi-
thelia are generally non-adhesive. In mouse embryo
implantation, the ErbB family receptor tyrosine
kinase (probably ErbB4) interacts with membrane-
bound heparin-binding epidermal growth factor
(EGF)-like growth factor (HB-EGF), which is in-
duced in the endometrial epithelia in a spatially
restrictedmanner by an implanting blastocyst [18, 19].
We hypothesized that such spatially and temporally
regulated and cell type-specific apical adhesion was
mediated by a unique adhesion molecule. We also
hypothesized that some cancer cell lines derived from
human embryonal carcinomas may exhibit activity of
trophectoderm cells at the implantation stage. As
human embryonal carcinoma cell lines tend to differ-
entiate into trophoblastic cells [20], we used the
human embryonal carcinomaHT-H line, which differ-
entiates spontaneously into trophoblastic cells [21].
When trophoblastic HT-H cells are added to a
monolayer of human endometrial epithelial SNG-M
cells, HT-H cells adhere rapidly to the upper surface of
the SNG-M cells [1]. Using both lines, we identified
gene products responsible for apical adhesion by
expression cloning. COS cells, which do not adhere to
the apical surface of SNG-M cells, were transfected
with an HT-H cDNA library constructed in a mam-
malian expression vector, and cells that then adhered
to SNG-M were selected. When a mixture of cDNA
clones was transfected, COS cells adhered to SNG-M
cells. However, no single cDNA from that pool
promoted adhesion. Thus clones were subtracted
from the original positive pool to identify potential
combinations of cDNAs required for adhesion. This
approach identified trophinin (TRO gene product)
and tastin (TROAP gene product) as necessary for
COS to adhere to SNG-M [1].
We found that trophinin and tastin do not interact
directly and subsequently identified within the pos-
itive cDNA pool a cytoplasmic protein that bridges
the two proteins [3]. This new protein was designated
bystin (BYSL gene product), as the gene encoding it is
homologous to Drosophila Bys (standing for by S
because it is next to the gene encoding ribosomal
protein S6) [22]. Bystin was likely missed in the initial
cloning of trophinin and tastin [1] because it is
expressed in COS cells.
In humans, theBYSL gene localizes to chromosome 6,
betweenTRFP encoding a transcriptionmediater and
CCND3 encoding cyclin D3 (Fig. 1a,b). The bystin
protein contains many potential protein kinase phos-
phorylation sites, suggesting an active role of bystin in
signal transduction (Fig. 1c). However, no known
structural motif is found in the bystin protein.
Bystin interacts with trophinin, tastin, and cytoker-
atins 8 and 18 [3]. Interestingly, interaction of bystin
with trophinin or tastin became stronger when cyto-
keratins 8 and 18 were included [3]. Such results
Figure 1. Structures of the human bystin gene BYSL and bystin
protein. (a) Genomic structure of the BYSL gene. BYSL maps to
chromosome 6, between TRFP encoding transcription mediator
and CCND3 encoding cyclin D3. (b) Transcription of the BYSL
gene. Untranslated region and translated regions are shown in blue
and red, respectively. (c) Human bystin protein. Potential phos-
phorylation sites of the human bystin protein for protein kinase C,
casein kinase II, and tyrosine kinase are shown in green, blue, and
red, respectively.
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suggest that the trophinin-bystin-tastin complex is
stabilized by cytokeratins. In the mouse, cytokeratins
8 (EndoA) and 18 (EndoB) are specific differentiation
markers for trophectoderm, which constitutes the first
differentiated cells of the fertilized egg [23]. We
hypothesize that cytokeratins stabilize the apical
localization of the trophinin-bystin-tastin complex in
trophectoderm cells prior to implantation.
At the human embryo implantation site, trophinin,
bystin, and tastin are strongly expressed in chorionic
trophoblasts and endometrial glandular epithelial
cells [4]. These three proteins are also expressed at
the implantation site in ectopic pregnancy, a condition
unique to humans [5]. Their expression patterns also
suggest that these proteins function in placental
development in humans.
The role of bystin in signal transduction following
trophinin-mediated cell adhesion
The histology of human implantation sites shows that
trophectoderm cells at the initial adhesion proliferate
and invade maternal tissue [14, 24]. By contrast,
trophectoderm cells at non-adherent sites remain
silent. Clearly, adhesion triggers transformation of
silent trophectoderm to an activated trophoblast in
vivo.
WhenHT-H cells were co-cultured on an endometrial
epithelial cell monolayer, the morphologies of both
cell types were altered [1, 25, 26]. Many microvilli on
the apical cell surfaces became flat and disappeared,
suggesting that initial apical adhesion mediated by
trophinin transduced a signal promoting cytoplasmic
reorganization in both cell types.
Because trophinin-mediated cell adhesion is based on
homophilic trophinin-trophinin binding, HT-H cells
also adhere to themselves [1]. Thus when HT-H cells
were detached from tissue culture plates by trypsin
treatment and added to anHT-H cell monolayer, they
adhered to that monolayer. Immunocytochemistry of
the HT-H monolayer after adhesion showed elevated
tyrosine phosphorylation [25], suggesting that trophi-
nin-mediated cell adhesion activated HT-H cells in
those cells.When the surface of HT-H cells was bound
with an anti-trophinin antibody and cross-linked using
a second antibody, tyrosine phosphorylation levels
and F-actin formation were increased, suggesting that
engagement of cell surface trophinin elicits an activa-
tion signal to the cytoplasm. To further investigate this
mechanism, we screened a peptide-displaying phage
library and identified a short GWRQ peptide that
mimics trophinin-mediated cell adhesion [25]. HT-H
cells cultured in the presence of GWRQ exhibited
higher mobility and proliferation than did cells
cultured with control peptide or without peptide.
When GWRQ was added to monkey blastocysts
cultured in vitro, trophectoderm cells migrated out
from the blastocyst, and total numbers of cells in the
blastocyst, including embryonic stem cells, increased
[25].
Using GWRQ peptide as a reagent mimicking tro-
phinin-mediated cell adhesion, we showed that the
cytoplasmic domain of trophinin arrests ErbB4, an
ErbB family receptor kinase, through bystin in HT-H
cells [25, 26]. When trophinin-mediated cell adhesion
occurs, which is mimicked by binding of GWRQ
peptide to the trophinin extracellular domain, bystin is
released from trophinin, allowing activation of ErbB4
and increasing proliferation and motility of tropho-
blastic cells. These results indicate that bystin plays a
key role in switching silent trophectoderm to activated
trophoblast.
The role of bystin in pre- and post-implantation stage
mouse embryos and in maternal uterine epithelia
When mouse blastocysts are returned to the uterus of
ovariectomized and progesterone-injected female
mice, blastocysts remain dormant or do not implant
[27, 28]. Activation occurs following estrogen injec-
tion into host mice. Microarray analysis of dormant
and activated mouse blastocysts showed that, among
several genes, Bysl expression was elevated in acti-
vated blastocysts [29].
Immunohistochemistry of mouse pre-implantation
stage embryos indicates that bystin is not expressed
or only weakly expressed in the fertilized egg earlier
than the blastocyst stage [30]. Bystin protein was not
detected in the blastocyst inside the zona pellucida,
while bystin expression was first detected during
hatching, and was then strongly expressed in the fully
expanded blastocyst (Fig. 2). After this stage, bystin
protein was down-regulated in trophectoderm cells
throughout the entire period of adhesion to the
maternal epithelia but reappeared in the epiblast
composed of pluripotent embryonic stem cells after
implantation. The expression pattern of mouse
bystin at peri-implantation [30] is similar to that of
mouse trophinin [6]. Bystin-null mouse embryos
implanted successfully but died soon after implanta-
tion [30], suggesting that bystin is essential for mouse
embryo survival after implantation. However, as
described below, Bysl gene knockdown experiments
show that bystin is also required for survival of pre-
implantation stage mouse embryos [12]. In the
knockout mouse, it is likely that maternally derived
Bysl mRNA masks loss of Bysl at pre-implantation
stages [30].
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When Bysl siRNAs were microinjected into fertilized
eggs, compaction at the eight-cell stage occurred
normally in vitro [12]. Bysl siRNA-injected embryos
showed slightly reduced expression of cytokeratin 8
(EndoA), an early trophectoderm marker [31]. While
control blastocysts showed assembled cytokeratin
structures in the trophectoderm layer, no organized
structures were detected in Bysl siRNA-injected
embryos. Consequently, blastocyst formation was
completely inhibited. These embryos failed to hatch
from the zona pellucida and could not outgrow in
culture. These results indicate that the bystin functions
in trophectoderm differentiation. Bysl knockdown
also inhibited embryonic stem cell proliferation [12].
Bystin is expressed in mouse endometrial luminal and
glandular epithelial cells throughout hormonal cycles
[30]. Interestingly, localization of bystin in the luminal
epithelia showed a distinct blastocyst-dependent pat-
tern: in the presence of blastocysts, bystin proteins
localized to the apical side of the epithelia, whereas in
their absence, bystin protein was localized to the
abluminal or basal side of the epithelia (Fig. 2). This
observation suggests the existence of an embryonic
factor affecting the localization of bystin in the
maternal epithelia. The molecular basis underlying
apical or basal localization of bystin is presently
unknown.
Drosophila bys for growth and cell adhesion
In Drosophila, the bys gene is implicated in cell
growth [9, 22, 32] and in cell-cell interaction [9].
Maternal bys is strongly expressed in cells exhibiting
high levels of rRNA synthesis and ribosome produc-
tion [9, 33]. In theDrosophila embryo, bys expression
is ubiquitous but relatively weak at early stages
(gastrulation, stage 9), but at later stages (germband-
extended embryos), bys expression is strong and
specifically localized, and in larval imaginal discs,
bys expression is restricted to specific patterns: for
example, bys is strongly expressed in the dorsal and
ventral regions of the wing pouch that will form
epithelia of the adult wing. These embryonic and
larval expression patterns could indicate a role of bys
in cell adhesion. In particular, bys expression is strong
in the region of the wing pouch giving rise to two
epithelial sheets of the adult wing that adhere to one
another after the disc everts.
The role of bystin in ribosomal biogenesis
Complementation analysis of budding yeast identified
an essential nuclear protein designated Enp1 [7], the
yeast bystin homolog.A temperature-sensitiveENP1-
null mutant showed defective processing of rRNA [8].
Studies of ribosomal biogenesis in yeast indicate that
Enp1 is required to synthesize 40S ribosomal subunits
by functioning in their nuclear export [34, 35].
While the expression of bystin in human tissues is
related to embryo implantation [4, 5], the expression
level of this protein is low in normal adult tissues [3].
A publicly available database shows that bystin
mRNA levels are relatively low in normal human
tissues, but that expression of bystin increases in
various tumor cells [13]. Other microarrays analyz-
ing specimens of human breast tumors identify bystin
as part of a proliferation cluster [36] . The embry-
onic lethality of theBysl-null mouse and observation
of bystin expression in the epiblast also support the
hypothesis that bystin is essential for rapid cell
growth in mammals, as both the epiblast and
embryonic stem cells should proliferate rapidly
after implantation. Bystin expression in the epiblast
is consistent with a report showing that Bysl is one of
216 genes commonly expressed in embryonic, neural
and hematopoietic stem cells in the mouse [37]. Thus
Bysl is a specific stem cell marker. Bysl is also
Figure 2. Expression of bystin protein in mouse embryos before,
during and after implantation. (a) Immunohistochemistry for
bystin in a blastocyst. Bystin protein was found in a blastocyst but
not detected in a fertilized mouse egg or embryos earlier than the
blastocyst stage [30]. (b) Bystin protein was barely detected in
trophectoderm cells (arrowhead) during implantation. (c) After
implantation, bystin protein was found in the epiblast including
embryonic stem cells (arrow). (d) In the pregnant mouse uterus or
in the presenceof blastocysts, bystin expression is seen on the apical
side of luminal epithelia (le), whereas it is distributed evenly in
glandular epithelia (ge). (e) Immunohistochemistry of the uterus of
a non-pregnant female mouse. Note that bystin proteins were
found at the abluminal side of endometrial luminal epithelia (le)
and glandular epithelia (ge). Tissue sections were reacted with
rabbit anti-bystin antibody [30], followed by biotinylated anti-
rabbit IgG antibody and peroxidase avidin. The peroxidase
substrate 3-amino-9-ethyl carbazole was used to detect immunos-
taining. Hematoxylin was used for counter-staining.
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included in a gene cluster of stem cell markers found
on mouse chromosome 16 [37].
Ribosomal biogenesis differs significantly between
prokaryotes and eukaryotes. In eubacteria, functional
ribosomes self-assemble and can be reconstituted in
vitro [38]. In budding yeast, ribosome synthesis
requires more than 150 non-ribosomal proteins,
many of which are essential for growth [39, 40].
These proteins have homologs in other species, and
some share properties with proteins found in mam-
malian pre-ribosomal complexes [41]. Some human
proteins, including fibrillarin [42], can complement at
least partially yeast strains with mutations in their
orthologs. Hence, a complex biogenesis system is
likely conserved in most eukaryotes, including hu-
mans. Eukaryotic ribosome formation occurs pre-
dominantly in nucleoli, but late maturation steps
occur in both the nucleoplasm and cytoplasm [40,
43].The location of bystin in the cytoplasm during G1
and its nuclear localization prior to mitosis [30]
suggest that bystin plays dual roles in cell growth
and proliferation in mammalian cells.
Several lines of evidence indicate that bystin functions
in ribosome biogenesis in human cells (Fig. 3). First, it
is located in the nucleolus, the organelle where
ribosomal biogenesis takes place [12, 13]. It is also
associated with the cytoplasmic 40S subunit, a com-
ponent of the 80S monosome, before translation is
initiated [13]. Bystin down-regulation delays process-
ing of 18S rRNA or the mature form required for
translation, resulting in compromised cell viability [12,
13]. In addition, inhibition of activity of the mamma-
lian target of rapamycin (mTOR) suppresses bystin
expression [13]. Furthermore, both nucleolar bystin
and bystin associated with the 40S subunit disappear
under conditions of nucleolar stress, suggesting that
bystins in both locations are functionally linked in
human cells [13]. Bystin may be associated with a
precursor of the 40S subunit – a pre-40S particle – in
the nucleolus and exported with these particles
through nuclear pores, where it dissociates from
particles at very late phases of subunit synthesis, as
has been shown for Enp1 [34]. Given the dependence
of cancer cell growth on ribosome biogenesis, high
bystin expression in cancer cells may contribute to
proliferation, a hypothesis supported by the fact that
the bystin gene is amplified in diffuse large B cell
lymphoma [44].
Although bystin exhibits activities similar to Enp1 [8,
34], human bystin cannot rescue the lethal phenotype
of a ENP1-null yeast mutant [8], suggesting that
ribosomal RNA processing pathways in multicellular
organisms differ from those in yeast [45] and that
bystin activities may have been modified during
evolution. In higher organisms, at early developmen-
tal stages, embryos must grow rapidly after implanta-
tion, requiring rapid ribosome biosynthesis. Bystin up-
regulation in the epiblast or in embryonic stem cells
[30] is consistent with the idea that bystin is linked to
rapid ribosomal biogenesis.
The C-terminal region of bystin/Enp1 sequences is
well conserved across eukaryotes [7, 8]. Previous
studies showed that human bystin binds trophinin,
tastin, and cytokeratin [3]. Human bystin also binds to
ErbB4 receptor tyrosine kinase [25]. However, it is
not known which part of the bystin polypeptide is
responsible for these binding activities. Some deletion
mutants of mouse bystin localized to the nucleolus
failed to rescue Bysl knockdown phenotypes and
suppressed proliferation of transfected cells [12].
However, bystin protein contains noknown functional
domains linked to these activities. Defining the
structure and function relationship of bystin awaits
future studies.
The cytoplasmic localization of bystin contrasts with
the almost exclusively nuclear localization of Enp1 in
yeast cells [7, 8, 34, 35]. Comprehensive proteomics
analysis of yeast nuclear proteins indicates that
nuclear proteins are not stored in the cytoplasm [34,
35]. Thus newly synthesized ribosomal proteins in the
cytoplasm are immediately transported to the nucle-
olus [46, 47]. Indeed, no cytoplasmic pool of nucleolar
fibrillarin and ribosomal S6 has been detected in
human cells [13]. Thus, the cytoplasmic localization of
Figure 3. Ribosomal biogenesis and rRNA processing in eukary-
otic cells. The initial pre-rRNA transcript is first transcribed from
repetitive ribosomal DNA genes by RNA polymerase I (Pol I) in
the nucleolus. rRNA precursors are then processed, chemically
modified, and folded in the nucleolus, and ribosomal proteins,
which are translated in the cytoplasm and imported into this
organelle, concomitantly assemble with pre-rRNAs [40, 46]. There
are two alternative pathways for rRNA processing in humanHeLa
cells [56]. Bystin is likely involved in processing of a 21S
intermediate, of which the final product, 18S rRNA, is included
in the 40S small subunit [13]. The importance of bystin homolog in
18S rRNA processing has also been shown in budding yeast [8] and
in mouse [12].
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bystin may have evolved in higher organisms. Bystin
function in cell adhesion during human embryo
implantation [3] suggests a cytoplasmic role in cell
adhesion and signal transduction [25]. In prostate
cancer cells, which adhere to neurons, bystin protein is
expressed in a manner suggesting a role in cell-cell
contact and cell growth [48].
For higher organisms, it was long believed that rRNA
processing is completed within the nucleus. However,
maturation of the 40S subunit, including final proc-
essing of 18S rRNA, has recently been demonstrated
to occur in the cytoplasm in human cells [reviewed in
ref. 43], as well as in yeast [40]. Since part of
cytoplasmic bystin is associated with the 40S subunit
before translation in human cells [13], bystin may also
function in the final step of 40S subunit synthesis in the
cytoplasm.
We found that bystin associates with undefined
nuclear particles following actinomycin D treatment
of HeLa cells [13]. Although these particles were
detected under conditions of bystin overexpression,
nucleolar stress-induced particles appear specific to
bystin. As nuclear stress granules can serve as storage
sites for transcription factors [49], soluble proteins
involved in ribosome biogenesis may shuttle between
the nucleolus and nucleoplasm [40, 47]. Given the
dependence of cell proliferation on ribosome bio-
genesis, when biogenesis is halted by nucleolar stress,
this system may allow rapid ribosome resynthesis
following relief from stress. Future proteomic analysis
of particles including tagged-bystin may define char-
acteristics of the bystin-containing nuclear particles as
has been shown with other nuclear particles [50, 51].
Cancer progression depends on ribosome biogenesis,
as exemplified by regulation of ribosome synthesis by
the tumor suppressors, pRb and p53, and RNA-
processing factors, including B23/nucleophosmin, are
involved in cancer progression [52]. Compounds such
as rapamycin, an inhibitor of ribosome biogenesis and
translation initiation, are effective anticancer drugs
[53]. Therefore, defining factors and pathways in-
volved in ribosome biogenesis is required for cancer
therapy. Just as many antibiotics interfere with the
formation of the prokaryotic ribosome [54], targeting
biogenesis of human ribosomes may antagonize
malignant neoplasms.
Bystin as a prominent c-MYC target
In Drosophila embryos, the expression pattern of bys
mRNA is almost identical to that of pitchoune (pit)
and modulo (mod) genes, which are potential tran-
scriptional targets of DrosophilaMyc (dMyc) [9]. As
the 5’ region of the Drosophila bys gene contains a
canonical E-box Myc-binding site, it is possible that
dMyc promotes bys gene expression in Drosophila.
Network reverse engineering, which enables identi-
fication of co-regulated genes from genome-wide
expression profiles, identified more than 100 first
neighbors or genes directly interconnected with the
MYC proto-oncogene in human B cells [55]. Intrigu-
ingly, BYSL was identified as the highest scored gene
co-regulated by MYC. This finding indicates that c-
MYC overexpression in human cells could lead to
ribosomal biogenesis and cellular overgrowth. Both c-
MYC and BYSL are overexpressed in many human
cancers, suggesting that bystin expression is associated
with malignant phenotypes.
Concluding remarks
In a wide variety of organisms from yeast to humans,
bystin and Enp1 play a role in facilitating ribosome
biogenesis required for cell growth. Drosophila bys
and human bystin are also involved in cell adhesion,
suggesting that bys and bystin acquired additional
functions during the course of evolution.
In higher organisms, many cellular functions are
controlled by cell-cell interactions. Embryo implanta-
tion and its subsequent processes for placenta for-
mation involve both cell-cell interactions and cell
growth. Although some mechanisms underlying ma-
lignant cancers are shared with those in embryo
implantation, distinct differences between them are
seen in their regulation: embryo implantation is a well
orchestrated and regulated process, while cancers
growwithout regulation. Further studies on bystin will
provide a better understanding of these processes and
could suggest novel therapeutic strategies against
malignant cancers.
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